Related Experiment Video
Updated: Apr 12, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Detection of Hepatitis B Virus Covalently Closed Circular DNA and Intermediates in Its Formation
Xupeng Hong1, Megan A Mendenhall1, Jianming Hu2
1Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
Insights
A new Southern blot method reliably detects Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA), the key to chronic infection persistence. This breakthrough aids in developing new HBV antivirals by improving cccDNA detection.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Chronic Hepatitis B virus (HBV) infection affects 294 million globally.
- Current antivirals fail to cure HBV due to persistent HBV covalently closed circular DNA (cccDNA) in hepatocytes.
- Lack of reliable cccDNA detection methods hinders the development of novel HBV therapies.
Purpose of the Study:
- To develop and validate a robust Southern blot method for accurate HBV cccDNA detection.
- To overcome challenges posed by low cccDNA abundance and interfering HBV DNA species.
- To facilitate research into cccDNA formation and maintenance for targeted drug development.
Main Methods:
- A modified Southern blot technique was employed.
- Efficient removal of contaminating plasmid DNA and linear HBV DNA species with free 3' ends was performed.
- Detection of HBV cccDNA was achieved using the optimized protocol.
Main Results:
- The described method reliably detects HBV cccDNA.
- The technique distinguishes cccDNA from other HBV DNA forms, even at low concentrations.
- Potential intermediates in cccDNA formation were also detectable.
Conclusions:
- This optimized Southern blot method provides a reliable tool for HBV cccDNA detection.
- Improved detection of cccDNA is crucial for understanding HBV persistence and developing curative therapies.
- The method supports the advancement of novel antiviral strategies targeting cccDNA.
Abstract:
Hepatitis B virus (HBV) infection remains a global public health issue, and approximately 294 million individuals worldwide are chronically infected with HBV. Approved antivirals rarely cure chronic HBV infection due to their inability to eliminate the HBV covalently closed circular DNA (cccDNA), the viral episome, in the nucleus of infected hepatocytes. The persistence of cccDNA underlies the chronic nature of HBV infection and the frequent relapse after the cessation of antiviral treatment. However, drug development targeting cccDNA formation and maintenance is hindered by the lack of sufficient biological knowledge on cccDNA, and of its reliable detection due to its low abundance and the presence of high levels of HBV DNA species similar to cccDNA. Here, we describe a Southern blot method for reliably detecting the HBV cccDNA even in the presence of high levels of plasmid DNA and other HBV DNA species, based on the efficient removal of plasmid DNA and all DNA species with free 3' ends. This approach also allows the detection of certain potential intermediates during cccDNA formation.
Related Concept Videos
Viruses with RNA Genomes
Hepatitis

